Niazi KR - Search Results

1

Molecular interaction of CD1b with lipoglycan antigens.

Ernst WA, Maher J, Cho S, Niazi KR, Chatterjee D, Moody DB, Besra GS, Watanabe Y, Jensen PE, Porcelli SA, Kronenberg M, Modlin RL. Ernst WA, et al. Among authors: niazi kr. Immunity. 1998 Mar;8(3):331-40. doi: 10.1016/s1074-7613(00)80538-5. Immunity. 1998. PMID: 9529150 Free article.

2

The CD1b structure: antigen presentation adapts to a high-fat diet.

Niazi KR, Porcelli SA, Modlin RL. Niazi KR, et al. Nat Immunol. 2002 Aug;3(8):703-4. doi: 10.1038/ni0802-703. Nat Immunol. 2002. PMID: 12145652 No abstract available.

3

The A' and F' pockets of human CD1b are both required for optimal presentation of lipid antigens to T cells.

Niazi K, Chiu M, Mendoza R, Degano M, Khurana S, Moody D, Melián A, Wilson I, Kronenberg M, Porcelli S, Modlin R. Niazi K, et al. J Immunol. 2001 Feb 15;166(4):2562-70. doi: 10.4049/jimmunol.166.4.2562. J Immunol. 2001. PMID: 11160317

4

The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens.

Jackman RM, Stenger S, Lee A, Moody DB, Rogers RA, Niazi KR, Sugita M, Modlin RL, Peters PJ, Porcelli SA. Jackman RM, et al. Among authors: niazi kr. Immunity. 1998 Mar;8(3):341-51. doi: 10.1016/s1074-7613(00)80539-7. Immunity. 1998. PMID: 9529151 Free article.

5

Molecular recognition of human CD1b antigen complexes: evidence for a common pattern of interaction with alpha beta TCRs.

Melián A, Watts GF, Shamshiev A, De Libero G, Clatworthy A, Vincent M, Brenner MB, Behar S, Niazi K, Modlin RL, Almo S, Ostrov D, Nathenson SG, Porcelli SA. Melián A, et al. J Immunol. 2000 Oct 15;165(8):4494-504. doi: 10.4049/jimmunol.165.8.4494. J Immunol. 2000. PMID: 11035089

6

Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis.

Stenger S, Niazi KR, Modlin RL. Stenger S, et al. Among authors: niazi kr. J Immunol. 1998 Oct 1;161(7):3582-8. J Immunol. 1998. PMID: 9759880

7

An antimicrobial activity of cytolytic T cells mediated by granulysin.

Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melián A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL. Stenger S, et al. Among authors: niazi kr. Science. 1998 Oct 2;282(5386):121-5. doi: 10.1126/science.282.5386.121. Science. 1998. PMID: 9756476

8

Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines.

Bleharski JR, Niazi KR, Sieling PA, Cheng G, Modlin RL. Bleharski JR, et al. Among authors: niazi kr. J Immunol. 2001 Sep 15;167(6):3174-81. doi: 10.4049/jimmunol.167.6.3174. J Immunol. 2001. PMID: 11544303

9

Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.

Niazi KR, Ochoa MT, Sieling PA, Rooke NE, Peter AK, Mollahan P, Dickey M, Rabizadeh S, Rea TH, Modlin RL. Niazi KR, et al. Immunology. 2007 Dec;122(4):522-31. doi: 10.1111/j.1365-2567.2007.02666.x. Epub 2007 Jul 16. Immunology. 2007. PMID: 17635609 Free PMC article.

10

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge.

Gabitzsch E, Safrit JT, Verma M, Rice A, Sieling P, Zakin L, Shin A, Morimoto B, Adisetiyo H, Wong R, Bezawada A, Dinkins K, Balint J, Peykov V, Garban H, Liu P, Bacon A, Bone P, Drew J, Sanford DC, Spilman P, Sender L, Rabizadeh S, Niazi K, Soon-Shiong P. Gabitzsch E, et al. Front Immunol. 2021 Sep 16;12:729837. doi: 10.3389/fimmu.2021.729837. eCollection 2021. Front Immunol. 2021. PMID: 34603305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters